Enter assignee name

Forward Citations = 2

Loading Chart...

13 inventors (with patents filed for the assignee):

Alex Franzusoff (6 out of 8 patents)

Kyle Jacoby (5 out of 7 patents)

Barbara Sennino (2 out of 8 patents)

4. Stefanie Mandl-Cashman (2 out of 4 patents)

5. Olivier Dalmas (2 out of 4 patents)

6. Songming Peng (2 out of 7 patents)

7. Michael M Dubreuil (1 out of 2 patents)

8. John Gagnon (1 out of 3 patents)

9. Michael Bethune (1 out of 2 patents)

10. Zheng Pan (1 out of 2 patents)

11. Boi Bryant Quach (1 out of 2 patents)

12. Duo An (1 out of 2 patents)

13. Xiaoyan Robert Bao (1 out of 3 patents)

7 patents: Sort by Forward Citations

1. 11513113 - Compositions and methods for identification of antigen specific T cells (2022-11-29),

2. 11304978 - Compositions and methods for the treatment of cancer using a CD8 engineered T cell therapy (2022-04-19),

3. 10875905 - Peptide-MHC compacts (2020-12-29),

4. 10711283 - Primary cell gene editing (2020-07-14),

5. 10676758 - Primary cell gene editing (2020-06-09),

6. 10584357 - Primary cell gene editing (2020-03-10),

7. 10550406 - Primary cell gene editing (2020-02-04),

Pact Pharma, Inc. is a biotechnology company focused on developing personalized cancer treatments using their proprietary technology platform. Their approach involves engineering neoantigen-specific T cells to target and kill cancer cells, with the goal of delivering more effective and targeted therapies for patients with various types of cancer. Pact Pharma is dedicated to advancing precision medicine and transforming the landscape of cancer treatment.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

7 Patents

#120 in South San Francisco, CA

#9,216 in California

#38,834 in US

South San Francisco, CA, United States of America

Pact Pharma, Inc.